These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN; Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591 [TBL] [Abstract][Full Text] [Related]
3. Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis. Brenner J; Mariotto S; Bastiaansen AEM; Paunovic M; Ferrari S; Alberti D; de Bruijn MAAM; Crijnen YS; Schreurs MWJ; Neuteboom RF; Damoiseaux JGMC; de Vries JM; Titulaer MJ Neurology; 2023 May; 100(21):e2204-e2213. PubMed ID: 37015822 [TBL] [Abstract][Full Text] [Related]
4. Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study. Truffi M; Garofalo M; Ricciardi A; Cotta Ramusino M; Perini G; Scaranzin S; Gastaldi M; Albasini S; Costa A; Chiavetta V; Corsi F; Morasso C; Gagliardi S Sci Rep; 2023 Mar; 13(1):4041. PubMed ID: 36899015 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders. Kammeyer R; Mizenko C; Sillau S; Richie A; Owens G; Nair KV; Alvarez E; Vollmer TL; Bennett JL; Piquet AL Front Neurol; 2022; 13():689975. PubMed ID: 35309573 [TBL] [Abstract][Full Text] [Related]
6. Serum neurofilament light chain as outcome marker for intensive care unit patients. Fisse AL; Pitarokoili K; Leppert D; Motte J; Pedreiturria X; Kappos L; Gold R; Kuhle J; Yoon MS J Neurol; 2021 Apr; 268(4):1323-1329. PubMed ID: 33098034 [TBL] [Abstract][Full Text] [Related]
7. Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus. Margraf NG; Dargvainiene J; Theel E; Leypoldt F; Lieb W; Franke A; Berger K; Kuhle J; Kuhlenbaeumer G J Neurol; 2023 Apr; 270(4):2128-2138. PubMed ID: 36624182 [TBL] [Abstract][Full Text] [Related]
8. Plasma neurofilament light chain levels predict improvement in late phase after stroke. Stokowska A; Bunketorp Käll L; Blomstrand C; Simrén J; Nilsson M; Zetterberg H; Blennow K; Pekny M; Pekna M Eur J Neurol; 2021 Jul; 28(7):2218-2228. PubMed ID: 33811783 [TBL] [Abstract][Full Text] [Related]
9. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease. Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136 [TBL] [Abstract][Full Text] [Related]